David Canton is a biotechnology professional with ten years of industry expertise in developing and implementing biomarker strategies for inflammatory diseases, including cancer. They have over 18 years of hands-on experience analyzing animal and human biomaterials using advanced technologies. David held leadership roles at OncoSec, where they were responsible for research and development efforts in clinical trials, and is currently serving as Associate Director of Biomarker Sciences at Avidity Biosciences, Inc. They hold a Ph.D. in Biochemistry from The University of Western Ontario and have participated in various research projects throughout their career. David is seeking new opportunities in biotech leadership to further advance therapeutic approaches.
This person is not in the org chart
This person is not in any teams
This person is not in any offices